Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Jan 28, 2022
Emerging Company Profile

TenSixteen: Targeting dynamic genome to find driver mutations, catch cancer earlier 

Foresite, GV lead $40M A round to build data platform, Dx assay
BioCentury | Jul 18, 2018
Distillery Techniques

Biomarkers

BioCentury | Dec 8, 2017
Targets & Mechanisms

Epiphenomena at ASH

Epigenetics and cell therapies are preclinical hotspots at ASH 2017
BioCentury | Sep 7, 2015
Clinical News

Imetelstat: Additional Phase II data

BioCentury | Oct 31, 2013
Distillery Techniques

Technology: Disease models

Items per page:
1 - 6 of 6